UniProt ID | RHG22_HUMAN | |
---|---|---|
UniProt AC | Q7Z5H3 | |
Protein Name | Rho GTPase-activating protein 22 | |
Gene Name | ARHGAP22 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 698 | |
Subcellular Localization | Cytoplasm. Nucleus. Mainly cytoplasmic. Some fraction is nuclear (By similarity).. | |
Protein Description | Rho GTPase-activating protein involved in the signal transduction pathway that regulates endothelial cell capillary tube formation during angiogenesis. Acts as a GTPase activator for the RAC1 by converting it to an inactive GDP-bound state. Inhibits RAC1-dependent lamellipodia formation. May also play a role in transcription regulation via its interaction with VEZF1, by regulating activity of the endothelin-1 (EDN1) promoter (By similarity).. | |
Protein Sequence | MLSPKIRQARRARSKSLVMGEQSRSPGRMPCPHRLGPVLKAGWLKKQRSIMKNWQQRWFVLRGDQLFYYKDKDEIKPQGFISLQGTQVTELPPGPEDPGKHLFEISPGGAGEREKVPANPEALLLMASSQRDMEDWVQAIRRVIWAPLGGGIFGQRLEETVHHERKYGPRLAPLLVEQCVDFIRERGLTEEGLFRMPGQANLVRDLQDSFDCGEKPLFDSTTDVHTVASLLKLYLRELPEPVVPFARYEDFLSCAQLLTKDEGEGTLELAKQVSNLPQANYNLLRYICKFLDEVQAYSNVNKMSVQNLATVFGPNILRPQVEDPVTIMEGTSLVQHLMTVLIRKHSQLFTAPVPEGPTSPRGGLQCAVGWGSEEVTRDSQGEPGGPGLPAHRTSSLDGAAVAVLSRTAPTGPGSRCSPGKKVQTLPSWKSSFRQPRSLSGSPKGGGSSLEVPIISSGGNWLMNGLSSLRGHRRASSGDRLKDSGSVQRLSTYDNVPAPGLVPGIPSVASMAWSGASSSESSVGGSLSSCTACRASDSSARSSLHTDWALEPSPLPSSSEDPKSLDLDHSMDEAGAGASNSEPSEPDSPTREHARRSEALQGLVTELRAELCRQRTEYERSVKRIEEGSADLRKRMSRLEEELDQEKKKYIMLEIKLRNSERAREDAERRNQLLQREMEEFFSTLGSLTVGAKGARAPK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
7 (in isoform 5) | Phosphorylation | - | 30.17 | 19664995 | |
14 | Phosphorylation | RQARRARSKSLVMGE HHHHHHHHCCCCCCC | 26.13 | 28857561 | |
16 | Phosphorylation | ARRARSKSLVMGEQS HHHHHHCCCCCCCCC | 27.69 | 22617229 | |
16 (in isoform 2) | Phosphorylation | - | 27.69 | 27251275 | |
23 | Phosphorylation | SLVMGEQSRSPGRMP CCCCCCCCCCCCCCC | 30.35 | 23312004 | |
25 | Phosphorylation | VMGEQSRSPGRMPCP CCCCCCCCCCCCCCC | 36.63 | 24961811 | |
44 (in isoform 4) | Phosphorylation | - | 4.93 | 28270605 | |
46 (in isoform 4) | Phosphorylation | - | 49.09 | 28270605 | |
47 (in isoform 4) | Phosphorylation | - | 42.65 | 28270605 | |
92 (in isoform 4) | Phosphorylation | - | 26.10 | 28152594 | |
97 (in isoform 4) | Phosphorylation | - | 61.46 | 28152594 | |
128 | Phosphorylation | EALLLMASSQRDMED HHHHHHHCCCCCHHH | 17.03 | 26471730 | |
129 | Phosphorylation | ALLLMASSQRDMEDW HHHHHHCCCCCHHHH | 21.50 | 26471730 | |
209 | Phosphorylation | LVRDLQDSFDCGEKP HHHHHHHHCCCCCCC | 15.26 | 24719451 | |
221 | Phosphorylation | EKPLFDSTTDVHTVA CCCCCCCCCCHHHHH | 28.94 | - | |
225 (in isoform 2) | Phosphorylation | - | 19.89 | 27251275 | |
229 | Phosphorylation | TDVHTVASLLKLYLR CCHHHHHHHHHHHHH | 29.87 | 24719451 | |
260 | Ubiquitination | SCAQLLTKDEGEGTL HHHHHHHCCCCCCHH | 54.47 | - | |
304 | Phosphorylation | YSNVNKMSVQNLATV HHCCCCCCHHHHHHH | 23.35 | - | |
310 | Phosphorylation | MSVQNLATVFGPNIL CCHHHHHHHHCCCCC | 21.38 | - | |
346 | Phosphorylation | TVLIRKHSQLFTAPV HHHHHHHHCCEECCC | 31.45 | 24247654 | |
350 | Phosphorylation | RKHSQLFTAPVPEGP HHHHCCEECCCCCCC | 38.35 | 23312004 | |
358 | Phosphorylation | APVPEGPTSPRGGLQ CCCCCCCCCCCCCEE | 63.32 | 22199227 | |
359 | Phosphorylation | PVPEGPTSPRGGLQC CCCCCCCCCCCCEEE | 18.74 | 22617229 | |
372 | Phosphorylation | QCAVGWGSEEVTRDS EEEEECCCCEECCCC | 24.87 | 28857561 | |
375 (in isoform 2) | Phosphorylation | - | 4.70 | 27251275 | |
376 | Phosphorylation | GWGSEEVTRDSQGEP ECCCCEECCCCCCCC | 31.85 | 27251275 | |
388 (in isoform 2) | Phosphorylation | - | 3.69 | 27251275 | |
393 | Phosphorylation | PGLPAHRTSSLDGAA CCCCCCCCCCCCCCE | 16.89 | 29255136 | |
394 | Phosphorylation | GLPAHRTSSLDGAAV CCCCCCCCCCCCCEE | 28.94 | 29255136 | |
395 | Phosphorylation | LPAHRTSSLDGAAVA CCCCCCCCCCCCEEE | 29.84 | 23401153 | |
411 (in isoform 2) | Phosphorylation | - | 24.42 | 27251275 | |
417 | Phosphorylation | TGPGSRCSPGKKVQT CCCCCCCCCCCCEEC | 35.26 | 24961811 | |
424 | Phosphorylation | SPGKKVQTLPSWKSS CCCCCEECCCCHHHH | 43.56 | 29514088 | |
427 | Phosphorylation | KKVQTLPSWKSSFRQ CCEECCCCHHHHCCC | 50.69 | 29083192 | |
430 | Phosphorylation | QTLPSWKSSFRQPRS ECCCCHHHHCCCCCC | 28.57 | 27251275 | |
431 | Phosphorylation | TLPSWKSSFRQPRSL CCCCHHHHCCCCCCC | 22.26 | 29083192 | |
437 | Phosphorylation | SSFRQPRSLSGSPKG HHCCCCCCCCCCCCC | 33.30 | 24706070 | |
439 | Phosphorylation | FRQPRSLSGSPKGGG CCCCCCCCCCCCCCC | 38.17 | - | |
441 | Phosphorylation | QPRSLSGSPKGGGSS CCCCCCCCCCCCCCC | 21.77 | 24706070 | |
447 | Phosphorylation | GSPKGGGSSLEVPII CCCCCCCCCCEEEEE | 34.72 | 24719451 | |
447 (in isoform 2) | Phosphorylation | - | 34.72 | 27251275 | |
466 | Phosphorylation | NWLMNGLSSLRGHRR CCHHHCHHHHCCCCC | 28.82 | 30301811 | |
467 | Phosphorylation | WLMNGLSSLRGHRRA CHHHCHHHHCCCCCC | 27.42 | 25954137 | |
476 | Phosphorylation | RGHRRASSGDRLKDS CCCCCCCCCCCCCCC | 43.67 | 21969604 | |
541 | Phosphorylation | ASDSSARSSLHTDWA CCCCCCCHHCCCCCC | 36.65 | 23401153 | |
542 | Phosphorylation | SDSSARSSLHTDWAL CCCCCCHHCCCCCCC | 20.72 | 22199227 | |
545 | Phosphorylation | SARSSLHTDWALEPS CCCHHCCCCCCCCCC | 38.23 | 22199227 | |
552 | Phosphorylation | TDWALEPSPLPSSSE CCCCCCCCCCCCCCC | 29.69 | 27251275 | |
556 | Phosphorylation | LEPSPLPSSSEDPKS CCCCCCCCCCCCCCC | 54.93 | 22199227 | |
557 | Phosphorylation | EPSPLPSSSEDPKSL CCCCCCCCCCCCCCC | 35.49 | 22199227 | |
558 | Phosphorylation | PSPLPSSSEDPKSLD CCCCCCCCCCCCCCC | 50.81 | 22199227 | |
561 (in isoform 2) | Phosphorylation | - | 24.88 | 27251275 | |
563 | Phosphorylation | SSSEDPKSLDLDHSM CCCCCCCCCCCCCCC | 32.29 | 29759185 | |
569 | Phosphorylation | KSLDLDHSMDEAGAG CCCCCCCCCCCCCCC | 27.82 | 27732954 | |
578 | Phosphorylation | DEAGAGASNSEPSEP CCCCCCCCCCCCCCC | 39.71 | 29978859 | |
580 | Phosphorylation | AGAGASNSEPSEPDS CCCCCCCCCCCCCCC | 48.68 | 22199227 | |
583 | Phosphorylation | GASNSEPSEPDSPTR CCCCCCCCCCCCCCH | 58.68 | 22199227 | |
587 | Phosphorylation | SEPSEPDSPTREHAR CCCCCCCCCCHHHHH | 38.60 | 23401153 | |
589 | Phosphorylation | PSEPDSPTREHARRS CCCCCCCCHHHHHHH | 53.28 | 22199227 | |
603 (in isoform 2) | Phosphorylation | - | 5.10 | 27251275 | |
636 | Phosphorylation | ADLRKRMSRLEEELD HHHHHHHHHHHHHHH | 37.43 | 24961811 | |
648 | Acetylation | ELDQEKKKYIMLEIK HHHHHHHHHEEEEEE | 51.59 | 7494173 | |
648 | Methylation | ELDQEKKKYIMLEIK HHHHHHHHHEEEEEE | 51.59 | 23644510 | |
649 | Phosphorylation | LDQEKKKYIMLEIKL HHHHHHHHEEEEEEC | 10.63 | - | |
655 | Acetylation | KYIMLEIKLRNSERA HHEEEEEECCCCHHH | 31.83 | 7494183 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
16 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RHG22_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RHG22_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
AGAP3_HUMAN | AGAP3 | physical | 28514442 | |
PI42C_HUMAN | PIP4K2C | physical | 28514442 | |
ATF1_HUMAN | ATF1 | physical | 28514442 | |
PI42B_HUMAN | PIP4K2B | physical | 28514442 | |
JUN_HUMAN | JUN | physical | 28514442 | |
KDM6A_HUMAN | KDM6A | physical | 28514442 | |
SIR6_HUMAN | SIRT6 | physical | 28514442 | |
CAF17_HUMAN | IBA57 | physical | 28514442 | |
DOC11_HUMAN | DOCK11 | physical | 28514442 | |
PLCD3_HUMAN | PLCD3 | physical | 28514442 | |
ATF2_HUMAN | ATF2 | physical | 28514442 | |
SRBD1_HUMAN | SRBD1 | physical | 28514442 | |
DAXX_HUMAN | DAXX | physical | 28514442 | |
KC1A_HUMAN | CSNK1A1 | physical | 28514442 | |
RAE1L_HUMAN | RAE1 | physical | 28514442 | |
PI42A_HUMAN | PIP4K2A | physical | 28514442 | |
CANB1_HUMAN | PPP3R1 | physical | 28514442 | |
KC1E_HUMAN | CSNK1E | physical | 28514442 | |
JUND_HUMAN | JUND | physical | 28514442 | |
PI51A_HUMAN | PIP5K1A | physical | 28514442 | |
PP2BC_HUMAN | PPP3CC | physical | 28514442 | |
CREB1_HUMAN | CREB1 | physical | 28514442 | |
SSBP2_HUMAN | SSBP2 | physical | 28514442 | |
ANK3_HUMAN | ANK3 | physical | 28514442 | |
TFCP2_HUMAN | TFCP2 | physical | 28514442 | |
PDD2L_HUMAN | PDCD2L | physical | 28514442 | |
ERI3_HUMAN | ERI3 | physical | 28514442 | |
ARMC8_HUMAN | ARMC8 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-395, AND MASSSPECTROMETRY. |